Spring 2017
April 20
Matthew Andrews, PhD (Kioussi host; LINC314 Corvallis)
“Pharmaceutical Development based on the Biochemistry of Hibernating Mammals”
Department of Biochemistry and Biophysics, OSU
May 4
Bob Tepper, MD (graduate students Singh host; LINC314 Corvallis)
“Building Transformational Biotechnology Companies to Deliver Novel Therapeutics”
Third Rock Ventures
May 18
Doug B. Pham, Pharm.D., J.D. (DeLander host; CSLB5S085 Portland)
Branch Chief, Compliance and Enforcement Branch (Acting), Office of Scientific Investigation FDA, CDER, Office of Compliance
“An FDA compliance perspective of drug development and the complex relationship of science and legal requirements when bringing a drug to market”.
May 25
Benjamin Tang, PhD (graduate students host; LINC314 Corvallis)
AMGEN “A windy path from chemical engineering to pharmacokinetics".
June 1
Samir Mitragotri, PhD (Sahay host; CSLB5S085 Portland)
“Understanding and Overcoming Biological Barriers for Drug Delivery”
University California Santa Barbara
June 8
Susan Carpenter, PhD and Thomas Carpenter, PhD (graduate students host; PHAR 305 Corvallis)
Amylin Pharmaceuticals, CA